GUIDA, Gabriella
 Distribuzione geografica
Continente #
EU - Europa 7.716
NA - Nord America 5.805
AS - Asia 1.641
SA - Sud America 536
AF - Africa 40
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 2
Totale 15.752
Nazione #
IT - Italia 5.738
US - Stati Uniti d'America 5.737
CN - Cina 532
SG - Singapore 532
BR - Brasile 487
SE - Svezia 372
HK - Hong Kong 356
RU - Federazione Russa 302
UA - Ucraina 255
DE - Germania 248
NL - Olanda 185
FI - Finlandia 160
GB - Regno Unito 155
FR - Francia 103
VN - Vietnam 48
CA - Canada 34
IN - India 33
BE - Belgio 32
PL - Polonia 28
AT - Austria 20
ID - Indonesia 20
MX - Messico 20
CH - Svizzera 19
BD - Bangladesh 18
ES - Italia 18
TR - Turchia 17
IE - Irlanda 16
ZA - Sudafrica 15
AR - Argentina 14
PK - Pakistan 14
CZ - Repubblica Ceca 11
IR - Iran 11
AL - Albania 10
AU - Australia 10
JP - Giappone 8
LT - Lituania 8
IQ - Iraq 7
JO - Giordania 7
RO - Romania 7
EC - Ecuador 6
TN - Tunisia 6
VE - Venezuela 6
CO - Colombia 5
KZ - Kazakistan 5
MA - Marocco 5
PY - Paraguay 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
DK - Danimarca 4
JM - Giamaica 4
LU - Lussemburgo 4
PT - Portogallo 4
AZ - Azerbaigian 3
BG - Bulgaria 3
BW - Botswana 3
CL - Cile 3
GR - Grecia 3
HN - Honduras 3
HU - Ungheria 3
IL - Israele 3
NO - Norvegia 3
NP - Nepal 3
PE - Perù 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
TW - Taiwan 3
CR - Costa Rica 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
EU - Europa 2
KE - Kenya 2
LK - Sri Lanka 2
NG - Nigeria 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
UY - Uruguay 2
AO - Angola 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
GE - Georgia 1
GT - Guatemala 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
MD - Moldavia 1
PA - Panama 1
PS - Palestinian Territory 1
SR - Suriname 1
TH - Thailandia 1
Totale 15.752
Città #
Chandler 662
Fairfield 519
Rome 506
Jacksonville 504
Woodbridge 485
Ashburn 414
Singapore 393
Hong Kong 355
Ann Arbor 316
Milan 272
Nyköping 259
Houston 235
Bari 224
Cambridge 222
Seattle 203
Wilmington 182
Naples 137
Lawrence 131
Roxbury 131
Nanjing 127
New York 116
Beijing 107
Bologna 103
Catania 86
Inglewood 83
Boardman 81
Des Moines 80
Napoli 57
Florence 56
Princeton 51
Padova 46
São Paulo 46
Turin 42
Los Angeles 41
Taranto 37
Helsinki 33
Munich 33
Parma 33
Nanchang 31
Hebei 30
Brooklyn 29
Dong Ket 29
Brussels 28
Dearborn 27
Tianjin 26
Santa Clara 25
Nuremberg 24
San Diego 24
Torino 24
Palermo 23
Perugia 23
Jiaxing 22
London 22
Lucca 22
Messina 22
Salerno 22
Belo Horizonte 20
Caserta 20
Jakarta 20
Pisa 20
Rio de Janeiro 20
Shenyang 20
Verona 20
Brescia 19
Pescara 19
Cagliari 18
Ferrara 18
Changsha 17
Redwood City 17
Dallas 16
Genoa 16
Latina 16
Mottola 16
San Francisco 16
Reggio Calabria 15
Vienna 14
Dublin 13
Guangzhou 13
Aversa 12
Vicenza 12
Augusta 11
Leawood 11
Moscow 11
Novara 11
San Mateo 11
Shanghai 11
Toronto 11
Turku 11
Afragola 10
Catanzaro 10
Ercolano 10
Jinan 10
Livorno 10
Montreal 10
The Dalles 10
Udine 10
Ardabil 9
Atlanta 9
Barletta 9
Bergamo 9
Totale 8.472
Nome #
FOSFORILAZIONE DEL FATTORE DI INIZIO DELLA TRADUZIONE eIF2 IN LINEE CELLULARI DI MELANOMA 6.069
Plasma-activated medium triggers cell death and the presentation of immune activating danger signals in melanoma and pancreatic cancer cells 162
Sporadic melanoma in South-Eastern Italy: the impact of melanocortin 1 receptor (MC1R) polymorphism analysis in low-risk people and report of three novel variants 155
New insight into the role of metabolic reprogramming in melanoma cells harboring braf mutations. 155
Influence of melanocortin-1 receptor (MC1R) polymorphisms on clinical outcomes of patients with metastatic melanoma harboring the BRAF mutation and treated with BRAF inhibitors 148
Aurora kinase B inhibition reduces the proliferation of metastatic melanoma cells and enhances the response to chemotherapy 145
Translational control mechanisms in cutaneous malignant melanoma: the role of eIF2α 140
Detrimental effects of melanocortin-1 receptor (MC1R) variants on the clinical outcomes of BRAF V600 metastatic melanoma patients treated with BRAF inhibitors 138
ANALISI MOLECOLARE E FUNZIONALE DEL RECETTORE MC1R NEL MELANOMA MALIGNO 132
MicroRNA expression in BRAF-mutated and wild-type metastatic melanoma and its correlation with response duration to BRAF inhibitors 123
Metastatic melanoma cells with BRAF G469A mutation: nab‑paclitaxel better than vemurafenib? 121
Association of Melanocortin-1 Receptor Variants with Pigmentary Traits in Humans: A Pooled Analysis from the M-Skip Project 119
Barasertib: a novel approach for the treatment of metastatic melanoma 110
Seasonal variations of Rana esculenta L. skin tyrosinase 109
MC1R genotype and psoriasis: is there a link revealing a phenotypic differences? 105
The relevance of BRAF G469A mutation in determining the response to therapy in metastatic melanoma 104
NEW HORIZONS IN TREATMENTS OF METASTATIC MELANOMA: THE ROLE OF TOMATINE 104
Spleen and liver pigmented macrophages of Rana esculenta L.A new melanogenic system? 103
The search for a melanoma-tailored chemotherapy in the new era of personalized therapy: a phase II study of chemo-modulating temozolomide followed by fotemustine and a cooperative study of GOIM (Gruppo Oncologico Italia Meridionale) 103
ULTRASTRUCTURE OF THE CELL WALL OF GRACILARIA C.F. VERRUCOSA (GRACILARIALES, RHODOPHYTA): EFFECTS OF STEAM EXPLOSION 102
Amphibian Kupffer Cells: TyrosinaseGene Expression 102
ACTIVATION OF DETOXIFYING ENZYMES IN TOMATO ROOTS FOLLOWING PARAQUAT TREATMENT AND NEMATODE INFECTION 101
The translation initiation factor eIF2 is hyperphosphorylated in melanoma cell lines 100
INCREASE IN RNA AND PROTEIN SYNTHESIS BY MITOCHONDRIA IRRADIATED WITH HELIUM-NEON LASER 100
The mitochondrial master regulator gene PGC1alpha in novel sporadic melanoma cell lines: correlations with BRAF mutational status. 98
Molecular and Ultrastructural analysis of a multiphasic oral malignant Melanoma 97
Negative influence of Melanocortin-1 receptor (MC1R) polymorphisms on clinical outcomes of metastatic melanoma (MM) patients (pts) harboring BRAF mutation and treated with BRAF inhibitors (BRAFi) 97
CARATTERIZZAZIONE DEL SISTEMA MELANOGENETICO DEI MELANOMACROFAGI 96
Genetic profiling of a rare condition: Co-occurrence of albinism and multiple primary melanoma in a caucasian family 96
The mitochondrial master regulator gene PGC1alpha in novel sporadic melanoma cell lines: correlations with BRAF mutational status 94
Metabolic reprogramming in melanoma: the role of peIF2 alpha 93
Tyrosinase gene expression in the Kupffer Cells of Rana esculentaL 91
MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort 91
The next generation of metastatic melanoma: Uncovering the genetic variants for anti-BRAF therapy response 88
CHARACTERIZATION OF THE SKIN MELANOGENETIC SYSTEM OF RANA ESCULENTA L 88
Effects of alpha-MSH on the tyrosinase system in Kupffer cells of Rana esulenta L 87
MC1R variants as melanoma risk factors independent of at-risk phenotypic characteristics: a pooled analysis from the M-SKIP project 86
A NOVEL APPROACH FOR THE TREATMENT OF METASTATIC MELANOMA 83
Molecular cloning and biochemical characterization of the skin tyrosinase from Rana esculenta L 83
Analysis of the enzymatic activity of the pigmented macrophages from liver and spleen of Rana esculenta L. 83
CARATTERIZZAZIONE DEL SISTEMA MELANOGENETICO CUTANEO DI RANA ESCULENTA L 82
Amphibian Kupffer Cells: Tyrosinase Gene Expression. 82
STUDIES ON PIGMENT CELLS FROM THE LIVER OF RANA ESCULENTA L 81
Caratterizzazione del sistema melanogenetico dei melanomacrofagi epatici di Rana esculenta L. 80
Aspetti molecolari della proliferazione cellulare e della metastatizzazione nel melanoma 80
EXPRESSION OF BASE EXCISION REPAIR KEY FACTORS AND miR17 IN FAMILIAL AND SPORADIC BREAST CANCER. 80
Stress response pathways driving tumorigenesis in melanoma cell lines. 80
Kupffer cell response to MSH in Rana esculenta L. 79
CARATTERIZZAZIONE DEL SISTEMA MELANOGENETICO DEI MELANOMACROFAGI 79
Active notch protects MAPK activated melanoma cell lines from MEK inhibitor cobimetinib 78
Phosphorilated ERK and eIF2alpha levels in melanoma cells. 77
THE INFLUENCE OF MC1R DERMAL MORPHOLOGICAL FEATURES OF PHOTOEXPOSED SKIN IN WOMEN REVEALED BY REFLECTANCE CONFOCAL MICROSCOPY AND OPTICAL COHERENCE TOMOGRAPHY 77
Three novel human sporadic melanoma cell lines: signaling pathways controlled by MC1R, BRAF and β-catenins 77
Attività Tirosinasica delle Cellule di Kupffer di Rana esculenta L. 75
Melanogenic response of the Kupffer cells of Rana esculenta L to melanocyte stimulating hormone 75
Analisi delle attività enzimatiche dei melanosomi isolati dai macrofagi pigmentati di Rana esculenta L 74
Optical spectroscopy of melanin films. 74
HELIUM-NEON LASER IRRADIATION OF RAT LIVER MITOCHONDRIA GIVES RISE TO A NEW SUBPOPULATION OF MITOCHONDRIA: ISOLATION AND FIRST BIOCHEMICAL CHARACTERIZATION 74
Analisi delle attività enzimatiche dei melanosomi isolati dai macrofagi pigmentati di Rana esculenta L. 73
Control of tyrosinase gene activation by 73
Analysis of the enzymatic activity of the pigmented macrophages from liver and spleen of Rana esculenta L 73
High activity of the Aurora B Kinase inhibitor AZD1152 on melanoma cell lines irrespective of BRAF mutation. 72
Correlazione tra stato mutazionale di MC1R ed outcomes clinici in pazienti (pts) affetti da melanoma metastaticoBRAF-mutati (MM) trattati con farmaci anti-BRAF 72
ACTIVATION OF DETOXIFYING ENZYMES IN TOMATO ROOTS FOLLOWING PARAQUAT TREATMENT AND NEMATODE INFECTION. NEMATOLOGIA MEDITERRANEA 72
Optical spectra of melanin films extracted from Rana Esculenta 71
PGC1 alpha expression and correlation with BRAF mutational status 71
Characterization of the melanogenic system in the SHK-1 cell line from Salmo salar L. Atlantic salmon 71
Optical and photoelectronic properties of Melanin Films. 70
Kupffer cell response to MSH in Rana esculenta L 70
Morphological and molecular characterization of a heterogeneous melanoma of the oral cavity 70
Analisi del sistema tirosinasico nella linea cellulare SHK-1 di Salmo Salar L. (Teleostei) 70
null 70
PRELIMINARY EVALUATION OF AN AGAR FRACTION OBTAINED FROM GRACILARIA VERRUCOSA 69
Optical Spectra of Melanin Films Extracted from Rana esculenta L 69
ATTIVITA' TIROSINASICA DELLE CELLULE DI KUPFFER DI RANA ESCULENTA L 68
PGC1 alpha EXPRESSION AND CORRELATION WITH BRAF MUTATIONAL STATUS 68
Control of tyrosinase gene activation by - MSH in Kupffer cells of Rana esculenta L. 67
Characterization of the skin tyrosinase from Rana esculenta L 67
Raman and optical spectroscopy of eumelanin films 67
“Differentiation in vitro of the hepatic pigment cells from Rana esculenta L. 66
ANALISI MOLECOLARE E FUNZIONALE DEL RECETTORE MC1R NEL MELANOMA MALIGNO 65
Tomatine displays antitumor potential in in vitro models of metastatic melanoma 64
Molecular characterization of novel melanoma cell lines 63
CHARACTERIZATION OF THE SKIN MELANOGENETIC SYSTEM OF RANA ESCULENTA L 63
Analisi del sistema tirosinasico nella linea cellulare SHK-1 di Salmo Salar L. (Teleostei) 62
null 62
THE MELANOGENIC SYSTEM OF THE LIVER PIGMENTED MACROPHAGES OF RANA ESCULENTA L. TYROSINASE ACTIVITY 61
Studio sui processi di proliferazione cellulare e metastatizzazione in nuove linee cellulari di melanoma. 58
MOLECULAR AND FUNCTIONAL ANALYSIS OF MC1R RECEPTOR IN MALIGNANT MELANOMA 58
Profilo proteomico di pazienti BRAF wild type trattati con temozolomide 57
Studio sulle cellule pigmentate di origine istiocitaria di Rana esculenta L. Espressione in vitro del gene della tirosinasi 57
Characterization of the tyrosinase enzyme of pigment cells from Rana esculenta L. liver 57
Characterization of the Skin Tyrosinase from Rana esculenta L. 56
OPTICAL SPETTROSCOPY OF MELANIN FILMS 55
Studio sulla regolazione della melanogenesi nei macrofagi pigmentati epatici di Rana esculenta L. 55
null 54
Nuove acquisizioni nella biologia del melanoma 54
Pigment Cell from Rana esculenta L. Spleen 54
MC1R RECEPTOR IN MALIGNANT MELANOMA: MOLECULAR AND FUNCTIONAL ANALYSIS 54
STUDIO SULLA REGOLAZIONE DELLA MELANOGENESI NEI MACROFAGI PIGMENTATIEPATICI DI RANA ESCULENTA L 53
Totale 14.406
Categoria #
all - tutte 49.851
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.851


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.792 173 62 147 54 242 106 265 107 168 185 155 128
2021/20221.377 68 135 43 41 83 125 80 84 98 80 217 323
2022/20232.381 251 176 138 216 259 232 153 313 349 55 93 146
2023/20241.614 123 129 90 68 106 235 263 208 71 91 85 145
2024/20253.460 260 80 290 139 204 322 382 310 169 158 459 687
2025/2026482 482 0 0 0 0 0 0 0 0 0 0 0
Totale 16.162